Integrum AB (publ) announced that the company has entered a Memorandum of Understanding with the Coapt LLC, with the intention to provide Integrum the possibility to combine Coapt's pattern recognition technology with the continued development of e-OPRATM Implant System. Coapt is the leading developer of advanced control solutions for prosthetics. Their primary product is a pattern recognition intent decoder system, called Complete Control, designed to enhance the functionality and user experience of upper-limb prostheses, allowing seamless and personalized movements.

The pattern recognition system uses machine learning algorithms, a form of artificial intelligence, or AI, to interpret electrical signals from the residual muscles of the amputee, which are then translated into movement. Complete Control continuously analyzes these signals, known as electromyographic signals, or EMG, to determine the intended movements of the user, allowing for more natural and intuitive control of the prosthetic limb. Integrum is developing the e-OPRATM Implant System, the upper-limb prosthetic control system using wired tissue-embedded electrodes.

e-OPRATM uses an implanted electrode system that both record and stimulate nerves and muscle tissues. By connecting this system with Coapt's pattern recognition technology, Integrum aims to further improve the functionality of e-OPRATM.